Understanding the basis of strain restricted immunity to Theileria parva
了解细小泰勒虫菌株限制性免疫的基础
基本信息
- 批准号:BB/H009515/1
- 负责人:
- 金额:$ 114.83万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2010
- 资助国家:英国
- 起止时间:2010 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Over 20% of people in sub-Saharan Africa are classified as living below the poverty line and many of these people reside in rural communities that are heavily dependent on livestock for their livelihoods. Infectious diseases have a major impact on livestock production in these regions. One of the most important diseases of cattle is East Coast fever (ECF) caused by a tick-borne parasite Theileria parva. This disease is present in 16 countries in eastern and southern Africa and it is the most economically important cattle disease in 11 of these countries. Estimates of economic losses due to ECF exceed 300 million US dollars annually. Imported breeds of cattle, which are increasingly being used to satisfy demands for milk production, are particularly susceptible. Although treatment of infected animals with anti-parasitic drugs and application of chemicals to prevent tick infestation can be used to control ECF, these methods are difficult to apply and generally are unaffordable by poor livestock keepers. Vaccination, therefore offers a more sustainable means of controlling the disease. Cattle can be immunised against the disease by infection with live parasites and simultaneous drug treatment, but the immunity induced by one parasite strain is not effective against all other strains. Use of a mixture of 3 parasite strains for vaccination has been found to give broad protection. This vaccine has been used locally with some success, but widespread application has been hindered by difficulties in production and distribution. The antigenic composition of the vaccine is poorly defined and there remain questions as to whether the content of parasite strains is optimal for obtaining robust immunity. More recently, antigens recognised by the protective cellular immune responses have been identified, with the aim of investigating their potential for developing a subunit vaccine. Preliminary evidence indicates that several of these antigens vary between parasite strains. Hence, understanding antigenic variability in T. parva is a key issue both for improving the current live vaccine and for the design of a sub-unit vaccine. The overall aim of the current project is to understand the antigenic basis of strain restricted immunity to T. parva, in order to develop improved vaccines against ECF. The key elements of the proposed research are: - An analysis of T. parva isolates from naturally infected cattle in different regions of Kenya, to determine the nature and extent of antigenic diversity in the parasite population. - An analysis of antigenic diversity in the 3 parasite isolates that make up the current live vaccine. - A detailed study of how variation in the antigens affects the ability of the cellular immune response to recognise different parasite strains. - An analysis of the specificity of cellular immune responses in cattle immunised sequentially and simultaneous with different parasite strains, to understand how these immunisation procedures affect the fine specificity of the immune response. - Analysis of immune Friesian cattle of different MHC genotypes for their ability to recognise currently defined T. parva antigens, in order to identify priorities for further antigen screening. It is anticipated that the results will provide methods for improving quality control of the current live vaccine, identify parasite strains that could be incorporated into an improved second generation live vaccine and indicate which and how many antigens will need to be incorporated into a subunit vaccine. Realisation of the project objectives will ultimately result in improved vaccines for ECF leading to better control of the disease. This will help to secure the assets and increase the incomes of smallholder and pastoral livestock keepers in affected regions. Improved disease control will result in increased production of meat and milk and reduce the levels of poverty in these vulnerable communities.
在撒哈拉以南非洲,超过20%的人生活在贫困线以下,其中许多人居住在严重依赖牲畜为生的农村社区。传染病对这些地区的畜牧业生产有重大影响。牛的最重要的疾病之一是由蜱传寄生虫小泰勒虫引起的东海岸热(ECF)。这种疾病存在于东部和南部非洲的16个国家,是其中11个国家经济上最重要的牛病。据估计,ECF造成的经济损失每年超过3亿美元。越来越多地用于满足牛奶生产需求的进口牛种特别容易受到影响。虽然用抗寄生虫药物治疗受感染的动物和应用化学品预防蜱虫感染可用于控制ECF,但这些方法难以应用,而且贫困的牲畜饲养者通常负担不起。因此,疫苗接种提供了一种更可持续的控制疾病的手段。牛可以通过感染活寄生虫并同时进行药物治疗来免疫疾病,但一种寄生虫菌株诱导的免疫力对所有其他菌株都无效。已发现使用3种寄生虫菌株的混合物进行疫苗接种可提供广泛的保护。这种疫苗已在当地使用,取得了一定的成功,但由于生产和分配方面的困难而阻碍了广泛应用。疫苗的抗原组成定义不明确,寄生虫菌株的含量是否是获得强大免疫力的最佳选择仍存在问题。最近,已经鉴定了由保护性细胞免疫应答识别的抗原,目的是研究它们用于开发亚单位疫苗的潜力。初步证据表明,这些抗原中有几种在寄生虫株之间存在差异。因此,了解T. parva是改进当前活疫苗和设计亚单位疫苗的关键问题。本项目的总体目标是了解T. parva,以开发针对ECF的改进疫苗。本研究的主要内容是:-对T。从肯尼亚不同地区的自然感染牛中分离parva,以确定寄生虫种群中抗原多样性的性质和程度。- 构成当前活疫苗的3种寄生虫分离株的抗原多样性分析。- 详细研究抗原的变化如何影响细胞免疫应答识别不同寄生虫菌株的能力。- 分析牛的细胞免疫反应的特异性,依次和同时免疫不同的寄生虫菌株,以了解这些免疫程序如何影响免疫反应的精细特异性。- 分析不同MHC基因型的免疫黑白花牛识别目前定义的T。parva抗原,以确定进一步抗原筛选的优先顺序。预期结果将提供用于改进当前活疫苗的质量控制的方法,鉴定可并入改进的第二代活疫苗中的寄生虫菌株,并指示哪些抗原和多少抗原将需要并入亚单位疫苗中。项目目标的实现将最终导致ECF疫苗的改进,从而更好地控制疾病。这将有助于确保受影响地区小农户和畜牧业者的资产并增加他们的收入。疾病控制的改善将导致肉类和牛奶产量的增加,并降低这些脆弱社区的贫困程度。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CD8 T-cell responses against the immunodominant Theileria parva peptide Tp249-59 are composed of two distinct populations specific for overlapping 11-mer and 10-mer epitopes.
- DOI:10.1111/imm.12637
- 发表时间:2016-10
- 期刊:
- 影响因子:6.4
- 作者:Connelley TK;Li X;MacHugh N;Colau D;Graham SP;van der Bruggen P;Taracha EL;Gill A;Morrison WI
- 通讯作者:Morrison WI
Genomic analysis offers insights into the evolution of the bovine TRA/TRD locus.
- DOI:10.1186/1471-2164-15-994
- 发表时间:2014-11-19
- 期刊:
- 影响因子:4.4
- 作者:Connelley TK;Degnan K;Longhi CW;Morrison WI
- 通讯作者:Morrison WI
Ancient diversity and geographical sub-structuring in African buffalo Theileria parva populations revealed through metagenetic analysis of antigen-encoding loci.
- DOI:10.1016/j.ijpara.2017.10.006
- 发表时间:2018-03
- 期刊:
- 影响因子:4
- 作者:Hemmink JD;Sitt T;Pelle R;de Klerk-Lorist LM;Shiels B;Toye PG;Morrison WI;Weir W
- 通讯作者:Weir W
Limited genetic and antigenic diversity within parasite isolates used in a live vaccine against Theileria parva.
- DOI:10.1016/j.ijpara.2016.02.007
- 发表时间:2016-07
- 期刊:
- 影响因子:4
- 作者:Hemmink JD;Weir W;MacHugh ND;Graham SP;Patel E;Paxton E;Shiels B;Toye PG;Morrison WI;Pelle R
- 通讯作者:Pelle R
NKp46+ CD3+ cells: a novel nonconventional T cell subset in cattle exhibiting both NK cell and T cell features.
- DOI:10.4049/jimmunol.1302464
- 发表时间:2014-04-15
- 期刊:
- 影响因子:0
- 作者:Connelley TK;Longhi C;Burrells A;Degnan K;Hope J;Allan AJ;Hammond JA;Storset AK;Morrison WI
- 通讯作者:Morrison WI
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivan Morrison其他文献
Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4.
通过单克隆抗体和功能表征表达 BoT4 的牛 T 淋巴细胞子集:与人 T4 和鼠 L3T4 定义的淋巴细胞相似。
- DOI:
- 发表时间:
1986 - 期刊:
- 影响因子:4.4
- 作者:
C. L. Baldwin;A. Teale;J. Naessens;B. Goddeeris;N. Machugh;Ivan Morrison - 通讯作者:
Ivan Morrison
Individual antigens of cattle. Antigens expressed predominantly on monocytes and granulocytes: identification of bovine CD11b and CD11c.
牛的个体抗原。
- DOI:
10.1016/0165-2427(91)90084-p - 发表时间:
1991 - 期刊:
- 影响因子:1.8
- 作者:
G. Splitter;Ivan Morrison - 通讯作者:
Ivan Morrison
Theileria annulata-transformed cell lines are efficient antigen-presenting cells for in vitro analysis of CD8 T cell responses to bovine herpesvirus-1
环状泰勒虫转化细胞系是有效的抗原呈递细胞,可用于体外分析 CD8 T 细胞对牛疱疹病毒 1 的反应
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:4.4
- 作者:
J. Hart;N. Machugh;Ivan Morrison - 通讯作者:
Ivan Morrison
Theileria parva感染症における免疫チェックポイント因子の動態解析
细小泰勒虫感染免疫检查点因素的动态分析
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
今内 覚、岡川朋弘、山田慎二、Martin Simuunza;Timothy Connelley;Ivan Morrison;村田史郎、大橋和彦 - 通讯作者:
村田史郎、大橋和彦
タイレリア感染による宿主細胞アポトーシス回避機構の解明
阐明泰勒虫感染引起的宿主细胞凋亡避免机制
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
林田京子;服部雅一;梶野喜一;Maura Wallace;Ivan Morrison;杉本千尋 - 通讯作者:
杉本千尋
Ivan Morrison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivan Morrison', 18)}}的其他基金
NKp46+CD3+ T-Cells As A Novel Target For Vaccines Against bovine TB
NKp46 CD3 T 细胞作为牛结核病疫苗的新靶点
- 批准号:
BB/N004647/1 - 财政年份:2016
- 资助金额:
$ 114.83万 - 项目类别:
Research Grant
The immunological basis of protection obtained by prime-boost immunisation against bovine tuberculosis
牛结核病初免-加强免疫获得保护的免疫学基础
- 批准号:
BB/K010018/1 - 财政年份:2013
- 资助金额:
$ 114.83万 - 项目类别:
Research Grant
Cameroon Zoonoses Collaboration Development
喀麦隆人畜共患病协作发展
- 批准号:
BB/J004006/1 - 财政年份:2011
- 资助金额:
$ 114.83万 - 项目类别:
Research Grant
相似国自然基金
基于Volatility Basis-set方法对上海大气二次有机气溶胶生成的模拟
- 批准号:41105102
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
求解Basis Pursuit问题的数值优化方法
- 批准号:11001128
- 批准年份:2010
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
TB方法在有机和生物大分子体系计算研究中的应用
- 批准号:20773047
- 批准年份:2007
- 资助金额:26.0 万元
- 项目类别:面上项目
相似海外基金
The genomic basis of environmental adaptation in house mice
家鼠环境适应的基因组基础
- 批准号:
10623622 - 财政年份:2023
- 资助金额:
$ 114.83万 - 项目类别:
Genetic basis of individual differences in itch sensitivity using mouse strain differences
利用小鼠品系差异研究瘙痒敏感性个体差异的遗传基础
- 批准号:
22K06058 - 财政年份:2022
- 资助金额:
$ 114.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Determing the genetic basis of responses to biomechanical strain in an in vitro model of osteoarthritis
确定骨关节炎体外模型中生物力学应变反应的遗传基础
- 批准号:
10538602 - 财政年份:2021
- 资助金额:
$ 114.83万 - 项目类别:
Determing the genetic basis of responses to biomechanical strain in an in vitro model of osteoarthritis
确定骨关节炎体外模型中生物力学应变反应的遗传基础
- 批准号:
10156429 - 财政年份:2021
- 资助金额:
$ 114.83万 - 项目类别:
Determing the genetic basis of responses to biomechanical strain in an in vitro model of osteoarthritis
确定骨关节炎体外模型中生物力学应变反应的遗传基础
- 批准号:
10348171 - 财政年份:2021
- 资助金额:
$ 114.83万 - 项目类别:
Structural basis of Rho glucosylation by Clostridium difficile toxins
艰难梭菌毒素 Rho 糖基化的结构基础
- 批准号:
10308686 - 财政年份:2020
- 资助金额:
$ 114.83万 - 项目类别:
The basis of strain-specific differences in virulence in the human pathogen Orientia tsutsugamushi
人类病原体恙虫病东方体毒力的菌株特异性差异的基础
- 批准号:
9891321 - 财政年份:2020
- 资助金额:
$ 114.83万 - 项目类别:
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
建立结核分枝杆菌药物反应改变的遗传基础
- 批准号:
10595538 - 财政年份:2019
- 资助金额:
$ 114.83万 - 项目类别:
The molecular basis of the carbapenem resistance epidemic
碳青霉烯类耐药流行的分子基础
- 批准号:
10065482 - 财政年份:2019
- 资助金额:
$ 114.83万 - 项目类别:
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
建立结核分枝杆菌药物反应改变的遗传基础
- 批准号:
10390301 - 财政年份:2019
- 资助金额:
$ 114.83万 - 项目类别:














{{item.name}}会员




